ArticleTherapeutic advances in urology2016

Degarelix monotherapy compared with luteinizing hormone-releasing hormone (LHRH) agonists plus anti-androgen flare protection in advanced prostate cancer: an analysis of two randomized controlled trials.

Peter Iversen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.